Abbott Gets FDA Clearance for Alinity M STI Assay
04 Mai 2022 - 03:42PM
Dow Jones News
By Chris Wack
Abbott Laboratories received clearance from the U.S. Food and
Drug Administration for its Alinity m STI Assay, the company said
Wednesday.
The test simultaneously detects and differentiates four common
sexually transmitted infections--Chlamydia trachomatis, Neisseria
gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium--and
requires one swab sample or a urine sample collected in a
healthcare setting by either a clinician or by the patient, the
company said.
The test runs on Abbott's Alinity m system, a high-volume
laboratory molecular instrument.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
May 04, 2022 09:27 ET (13:27 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024